Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7220823 Transmembrane protein expressed in prostate and other cancers

Patent 7220823 was granted and assigned to Agensys on May, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rene S. Hubert0

Daniel E. Afar0

Douglas C. Saffran0

Kahan Leong0

Arthur B. Raitano0

Date of Patent

May 22, 2007

0

Patent Application Number

102850450

Date Filed

October 30, 2002

0

Patent Primary Examiner

0

Patent abstract

A novel prostate tumor associated gene (designated 24P4C12) and its encoded protein is described. 24P4C12 is highly expressed in prostate tissue xenografts, providing evidence that it is turned on in at least some prostate cancers. 24P4C12 provides a diagnostic and/or therapeutic target for prostate and other cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7220823 Transmembrane protein expressed in prostate and other cancers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.